Suchergebnisse - "Boesjes, Celeste"

PubPharm (20)

1

Influence of pathogenic filaggrin variants on dupilumab treatment in atopic dermatitis

enthalten in: The Journal of allergy and clinical immunology | 2024

von Clabbers, J. | Boesjes, C. | Spekhorst, L. | +11

2

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis : up to 5-year results from the daily practice BioDay Registry

enthalten in: Journal of the American Academy of Dermatology | 2024

von Zhang, J. | Boesjes, C. | Loman, L. | +21

3

Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024

von Boesjes, C. | Bakker, D. | Knol, E. | +3

4

Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis : a randomized controlled observer-blind pragmatic trial (ABC trial)

enthalten in: The British journal of dermatology | 2024

von Ragamin, A. | Schappin, R. | de Graaf, M. | +12

CommentIn: Br J Dermatol. 2024 Feb 16;190(3):e29. - PMID 38366831

5

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema : Up to 28-week Results from the BioDay Registry

enthalten in: Acta dermato-venereologica | 2024

von Kamphuis, E. | Boesjes, C. | Loman, L. | +8

6

Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis

enthalten in: JAMA dermatology | 2023

von Boesjes, C. | van der Gang, L. | Bakker, D. | +5

CommentIn: JAMA Dermatol. 2023 Nov 1;159(11):1177-1178. - PMID 37851433

7

Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity : a large pragmatic daily practice study from the BioDay registry

enthalten in: The British journal of dermatology | 2023

von Spekhorst, L. | Boesjes, C. | Loman, L. | +15

CommentIn: Br J Dermatol. 2023 Aug 24;189(3):e68. - PMID 37620024

8

Muscle and joint pain during dupilumab treatment for atopic dermatitis : Lack of association with antinuclear antibodies

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Boesjes, C. | van Emst, M. | Bakker, D. | +4

9

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib : Results from the BioDay Registry

enthalten in: Acta dermato-venereologica | 2023

von Boesjes, C. | Van der Gang, L. | Zuithoff, N. | +6

10

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis : 28-week clinical and biomarker results from the BioDay registry

enthalten in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology | 2022

von Kamphuis, E. | Boesjes, C. | Loman, L. | +9

CommentIn: J Am Acad Dermatol. 2023 Apr;88(4):e157-e160. - PMID 36646136